Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

50.750
-1.450-2.78%
Volume:88.95M
Turnover:4.62B
Market Cap:210.36B
PE:43.72
High:54.450
Open:53.150
Low:50.300
Close:52.200
52wk High:54.450
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:1.83
T/O Rate:2.15%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.161
ROE:11.64%
ROA:6.88%
PB:3.82
PE(LYR):43.72
PS:8.28

Loading ...

Akari Net Loss Widens to $4.81 Million in Q2 FY26; Operating Loss Rises to $4.6 Million

Reuters
·
Aug 14

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

Stock News
·
Aug 13

HK Movers | Hong Kong Biotech Stocks Rally; Genscript Bio Jumps Over 7%, Zai Lab Gains Over 6%

Tiger Newspress
·
Aug 11

Movement Alert|WUXI BIO Rises 3.08% in Regular Trading, CXO Sector Recovery Signals Strengthened by Peer Earnings Beat and Acquisition Expansion

Market Focus
·
Aug 11

CRO Sector Surges as Wuxi Apptec Secures US Court Injunction, Suspending Defense Department Listing

Stock News
·
Aug 10

HK Movers | Pharma Stocks Jump With Viva Biotech up 15%, WuXi XDC, WuXi Biologics up 6%

Tiger Newspress
·
Aug 10

Stock Track | WUXI BIO Soars 5.10% Intraday on Acquisition Deal and Sector Tailwinds

Stock Track
·
Aug 10

Movement Alert|WUXI BIO Rises 4.75% in Regular Trading, CXO Sector Momentum Continues Amid Acquisition and Earnings Catalysts

Market Focus
·
Aug 10

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

Stock News
·
Aug 07

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

Stock News
·
Aug 07

WuXi Bio Co., Ltd. gains nearly 6% in early trading, plans to acquire ChuangSheng Pharma's process development and manufacturing base in Hangzhou

Deep News
·
Aug 07

Movement Alert|WUXI BIO Rises 3.19% in Regular Trading, CXO Sector Rallies on Strong Peer Earnings and Upcoming Interim Results

Market Focus
·
Aug 07

Transcenta Agrees to Sell CDMO Assets to WuXi Biologics Unit for RMB 190 Million

Reuters
·
Aug 07

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

Reuters
·
Aug 06

Wuxi Biologics (Cayman) Stock Advances 1.9% in Hong Kong

Dow Jones
·
Aug 06

Movement Alert|WUXI BIO Rises 3.1% in Regular Trading, CXO Sector Strength and Interim Earnings Expectations Serve as Catalysts

Market Focus
·
Aug 06

Wuxi Biologics (Cayman) Stock Climbs 4.3% in Hong Kong

Dow Jones
·
Aug 04

CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance

Stock News
·
Aug 04

Hong Kong Market Opens Higher as Pharma and Tech Stocks Lead Gains

Stock News
·
Aug 04

Movement Alert|WUXI BIO Rises 4.85% in Regular Trading, CXO Sector Broad Rally Lifts Life Sciences Stocks

Market Focus
·
Aug 04